Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.9200 (1.02%) ($7.7100 - $8.0500) on Wed. May. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.2% (three month average) | RSI | 49 | Latest Price | $7.9200(1.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UUP(6%) XLC(4%) BLOK(2%) TBT(2%) VXX(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.6% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.6% (StdDev 3.2%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
5 Day Moving Average | $7.85(0.89%) | 10 Day Moving Average | $7.81(1.41%) | 20 Day Moving Average | $7.79(1.67%) | To recent high | -13.4% | To recent low | 8.8% | Market Cap | $1.397b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |